One of the most utilized tools in biomedical research is the monoclonal antibody. These proteins have the potential to seek out and bind to any desired target, and can be used for cell imaging ...

Therapeutic antibodies have become one of the fastest-growing drug classes used to treat cancer and autoimmune diseases. To find the most promising antibody, biotechnology and pharmaceutical ...

An antigen is any substance that prompts your body to trigger an immune response against it. Antigens include allergens, bacteria and viruses. Antibodies are Y-shaped proteins that the body produces ...

A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.

Antibodies are proteins that circulate in the blood and protect against foreign antigenic substances such as bacteria, viruses, fungi, parasites, chemicals, or toxins. They are Y-shaped structures ...

An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody ...

Scientists have engineered an antibody that attacks 99% of HIV strains and can prevent infection in primates. It is built to attack three critical parts of the virus - making it harder for HIV to ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

In the United States, envenomation (the injection of venom) usually happens during an encounter with a snake, spider, or insect. Antivenom (often spelled “antivenin”) is an antibody product that can ...

Stefano Gullà, chief scientific officer at Kling Biotherapeutics, discusses how new approaches in antibody research technology could halt this and other outbreaks. Mpox is spreading rapidly in ...

In a groundbreaking discovery, researchers at The University of Texas at Austin have identified an antibody capable of ...

Weizmann Institute of Science researchers present a new algorithm to greatly speed up the process of engineering therapeutic proteins to protect against diseases. Researchers at the Weizmann ...